WO2014034958A1 - Method for producing oxazole compound - Google Patents
Method for producing oxazole compound Download PDFInfo
- Publication number
- WO2014034958A1 WO2014034958A1 PCT/JP2013/073854 JP2013073854W WO2014034958A1 WO 2014034958 A1 WO2014034958 A1 WO 2014034958A1 JP 2013073854 W JP2013073854 W JP 2013073854W WO 2014034958 A1 WO2014034958 A1 WO 2014034958A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound represented
- compound
- lower alkyl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *Oc(ccc(-c1nc(CO)c[o]1)c1)c1O* Chemical compound *Oc(ccc(-c1nc(CO)c[o]1)c1)c1O* 0.000 description 5
- HIOYTPFJMOZCNT-UHFFFAOYSA-N CC(C)Oc1cc(C(N)=O)ccc1C Chemical compound CC(C)Oc1cc(C(N)=O)ccc1C HIOYTPFJMOZCNT-UHFFFAOYSA-N 0.000 description 1
- RBBSYZXPKDREGZ-UHFFFAOYSA-N CC(C)Oc1cc(C(O)=O)ccc1OCc1ccccc1 Chemical compound CC(C)Oc1cc(C(O)=O)ccc1OCc1ccccc1 RBBSYZXPKDREGZ-UHFFFAOYSA-N 0.000 description 1
- HBVDTTVDDFFYOC-UHFFFAOYSA-N CCOC(C(C=C1O)=CCC1OCc1ccccc1)=O Chemical compound CCOC(C(C=C1O)=CCC1OCc1ccccc1)=O HBVDTTVDDFFYOC-UHFFFAOYSA-N 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N O=C(c1ccccc11)NC1=O Chemical compound O=C(c1ccccc11)NC1=O XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Definitions
- the present invention relates to a novel method for producing an oxazole compound.
- Patent Literature 1 reports an oxazole compound that exhibits a specific inhibitory activity against phosphodiesterase 4 (PDE4).
- Patent Literature 1 discloses a method for producing an oxazole compound. It indicates, as a typical method thereof.
- the starting material dihaloketone compound (12) exhibits strong stimulant and tearing properties; and, furthermore, because hydrazine (17) has a risk of explosion during the processes of concentration and dehydration, it is preferable to avoid the use thereof for the health and safety of the people involved in its production.
- An object of the present invention is to provide a novel method for producing an oxazole compound.
- the present invention provides the method for producing an oxazole compound described below.
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- Item 2 The compound according to Item 1, wherein in formula (12), R 1 is methyl or difluoromethyl group, and R 2 is methyl, isopropyl, or isobutyl group.
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- R 5 is lower alkyl group
- R 11 is lower alkyl group, halogen substituted lower alkyl group, or a group represented by formula: -CY 2 COOR 12 , wherein Y is a halogen atom, R 12 is an alkali metal atom or lower alkyl group, and X 2 and X 3 are the same or different and are halogen atoms,
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- R 5 is lower alkyl group
- R 11 is lower alkyl group
- Y is a halogen atom
- R 12 is an alkali metal atom or lower alkyl group
- Ar 1 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group, or pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- X 2 , X 3 and X 9 are the same or different and are halogen atoms
- X 4 is a leaving group
- M is an alkali metal atom
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- Ar 1 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group , halogen substituted lower alkyl group , lower alkox group and halogen substituted lower alkoxy group, or a pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen
- X 9 is a halogen atom
- X 4 is a leaving group
- M is an alkali metal atom
- Item 7 A method for producing a compound represented b formula (12),
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- R 7 is lower alkanoyl group
- X 8 is a halogen atom
- R 11 is lower alkyl group , halogen substituted lower alkyl group or a group represented by formula: -CY 2 COOR 12 , wherein Y is a halogen atom, R 12 is an alkali metal atom or lower alkyl group, X 3 is a halogen atom, and R 1 and R 2 are as defined above,
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- R 7 is lower alkanoyl grou
- Ar 1 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen
- Item 10 A method for producing a compound represented by formula ( 1) ,
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- R 5 is lower alkyl group
- Ar 1 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group , lower alkoxy group and halogen substituted lower alkoxy group , or a pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- X 2 and X 9 are the same or different and are halogen atoms
- X 4 is a leaving group
- M is an alkali metal atom
- Item 11 A method for producing a compound represented by formula ( 2 ) ,
- R is lower alkyl group or halogen substituted lower alkyl group
- R 4 is lower alkyl group, cycloalkyl-lower alkyl group, or lower alkenyl group
- R 5 is lower alkyl group
- R 6 is lower alkyl group
- Ar 2 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group , or pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group , halogen substituted lower alkyl group , lower alkoxy group and halogen substituted lower alkoxy group
- X 2 and X 7 are the same or different and are halogen atoms
- X 5 is a leaving group.
- the present invention relates to a novel method for producing an oxazole compound. Because this method does not use a dihaloketone compound and hydrazine throughout the production processes thereof, it is preferable from the viewpoint of the health and/or safety of the people who are involved in its production. Furthermore, because this method allows the isolation and purification of the target product without using expensive and complicated column chromatography throughout the production process, it is preferably employed as an effective method on an industrial scale.
- R 1 is lower alkyl group or halogen substituted lower alkyl group
- R 2 is lower alkyl group
- R 5 is lower alkyl group
- R 11 is lower alkyl group
- Y is a halogen atom
- R 12 is an alkali metal atom or lower alkyl group
- Ar 1 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group , halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group, or pyridyl group substituted with at least one substituent
- X 1 , X 2 , X 3 and X 9 are the same or different and are halogen atoms, X 4 is a leaving group, and M is an alkali metal atom.
- Compound (3) ⁇ (3' ) can be produced by reacting compound (3) with compound (4) in the presence of a base.
- Examples of lower alkyl groups represented by R 2 include Ci-C 6 (in particular, Ci-C 4 ) linear or branched alkyl groups.
- methyl, ethyl, isopropyl, isobutyl are preferable, and isopropyl and isobutyl are more preferable.
- halogen atoms represented by X 1 include fluorine, chlorine, bromine, and iodine. Among these, chlorine, bromine, and iodine are preferable.
- the reaction described above generally can be conducted in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- ketone solvents e.g., acetone and methyl ethyl ketone
- ether solvents e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane, and diglyme
- ester solvents e.g., methyl acetate and ethyl acetate
- aprotic polar solvents e.g., acetonitrile, iV,iV-dimethylformamide, and
- dimethylsulfoxide dimethylsulfoxide
- halogenated hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., JV,lV-dimethylformamide is preferable.
- inorganic and organic bases can be used as the bases.
- inorganic bases include alkali metal
- hydrogencarbonates e.g., lithium hydrogencarbonate, sodium hydrogencarbonate, and potassium hydrogencarbonate
- alkali metal hydroxides e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide
- alkali metal carbonates e.g., lithium carbonate, sodium carbonate, potassium carbonate, and cesium carbonate
- alkali metal lower ( Ci-C 3 ) alkoxides e.g., sodium methoxide and sodium ethoxide
- organic bases include trialkylamines (e.g., trimethylamine, triethylamine, and W,N-diisopropylethylamine) , pyridine, quinoline, piperidine, imidazole, picoline, 4-dimethylaminopyridine, JV,]7-dimethylaniline, iV-methylmorpholine, l,5-diazabicyclo[4.3.0]non-5-ene (DBN) , 1,4- diazabicyclo[2.2.2]octane (DABCO) , and 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU) .
- trialkylamines e.g., trimethylamine, triethylamine, and W,N-diisopropylethylamine
- pyridine quinoline
- piperidine imidazole
- picoline 4-dimethylaminopyridine
- these bases When these bases are in a liquid form, they may also be used as a solvent. These bases may be used singly or as a mixture of two or more. Among these, alkali metal carbonates (in particular, sodium carbonate, potassium carbonate, cesium carbonate, etc.) are preferable.
- the amount of base used is generally 0.5 to 10 mol, and preferably 0.5 to 6 mol per mole of a compound represented by formula (3) .
- alkali metal iodides such as potassium iodide and sodium iodide may be added to the reaction system as reaction accelerators, if necessary.
- the amount used is at least 1 mol, and preferably about 1 to 5 mol per mole of compound ( 4) .
- the proportion between compound (3) and compound (4) is generally at least 1 mol, and preferably about 1 to 5 mol of compound ( 4 ) per mole of compound ( 3) .
- the reaction temperature is not particularly limited, and the reaction may generally be conducted either under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of near room temperature to about 85° C for 1 to 30 hours.
- Compound (5) can be produced by hydrolyzing compound
- the hydrolysis reaction of compound (3' ) may be conducted generally in a solvent and in the presence of a base.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include water, alcoholic solvents (e.g., methanol, ethanol, isopropanol, and n-butanol), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane,
- diethylether, dimethoxyethane, and diglyme), and acetonitrile Among these, mixed solvents of water and an alcoholic solvent (methanol or ethanol) are preferable. Alcoholic solvents (in particular, methanol and ethanol) are particularly preferable.
- bases examples include alkali metal hydroxides (e.g. , lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide).
- alkali metal hydroxides can be used in the form of an aqueous solution thereof.
- a sodium hydroxide aqueous solution may be mentioned.
- the amount of base used is at least 1 mol, and preferably about 1 to 5 mol per mole of compound (3').
- the reaction temperature is not particularly limited, and the reaction may generally be conducted either under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of near room temperature to about 85° C for 1 to 30 hours.
- Compound (6) can be produced by subjecting compound (5) to a condensation reaction with ammonia (amidation).
- the reaction may generally be conducted by reacting compound (5) with ammonia in a solvent and in the presence of a condensing agent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include halogenated aliphatic hydrocarbon solvents (e.g., methylene chloride, chloroform, and ethylene chloride), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane, and diglyme), aromatic hydrocarbons (e.g., toluene and xylene), aprotic polar solvents (e.g., acetonitrile, JV,iV-dimethylformamide, N-methylpyrrolidone, and dimethylsulfoxide) , and mixed solvents thereof.
- acetonitrile is preferable.
- condensing agents examples include 1,1'- carbonyldiimidazole (CDI), dicyclohexylcarbodiimide (DCC) ,
- DIC diisopropylcarbodiimide
- EDC 1-ethyl-3- (3- dimethylaminopropyl)carbodiimide hydrochloride
- WSC diphenylphosphoryl azide
- benzotriazol-l-yloxy- tris(dimethylamino)phosphonium salt e.g., benzotriazol-l-yloxy- tris(dimethylamino)phosphonium hexafluorophosphate
- CDM 2- chloro-4, 6-dimethoxytriazine
- the amount of condensing agent used is generally at least 1 mol, and preferably about 1 to 5 mol per mole of compound (5).
- 1-Hydroxybenzotriazole (HOBt), IV-hydroxysuccinimide (HOSu) and the like may be used as an additive (activator) in combination with a condensing agent, if necessary.
- the amount thereof is generally at least 1 mol, and preferably about 1 to 5 mol per mole of condensing agent.
- the reaction may be conducted by adding a base, if necessary.
- bases include tertiary amines such as triethylamine and N,iV-diisopropylethylamine; and nitrogen- containing aromatic compounds such as pyridine and 4- dimethylaminopyridine.
- the amount thereof is generally at least 1 mol, and preferably about 1 to 5 mol per mole of compound ( 5) .
- Aqueous ammonia can generally be used as ammonia.
- the amount of ammonia used is generally at least 1 mol, and preferably about 1 to 10 mol per mole of compound (5).
- this reaction may be conducted by reacting compound (5) with a condensing agent and optionally an additive to prepare an active ester, and further reacting the resulting mixture with ammonia.
- reaction temperatures for the preparation of the active ester and the subsequent reaction with ammonia are not particularly limited, and either may generally be conducted under cooling, at room temperature, or under heating. Preferably, the reaction is conducted under temperature conditions of about ice cooling to room temperature for 1 to 30 hours.
- Compound (6 ) ⁇ ( 8) is not particularly limited, and either may generally be conducted under cooling, at room temperature, or under heating. Preferably, the reaction is conducted under temperature conditions of about ice cooling to room temperature for 1 to 30 hours.
- Compound (8) can be produced by reacting compound (6) with compound ( 7 ) .
- halogen atoms represented by X 2 include fluorine, chlorine, bromine, and iodine. Among these, chlorine, bromine, and iodine are preferable, and bromine is particularly preferable.
- Examples of lower alkyl groups represented by R 5 include Ci-C 6 (in particular, Ci-C 3 ) linear or branched alkyl groups.
- methyl and ethyl are preferable.
- the reaction can generally be conducted in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction. Examples thereof include water, alcoholic solvents (e.g., methanol, ethanol, isopropanol, n-butanol, trifluoroethanol, and ethylene glycol), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether,
- alcoholic solvents e.g., methanol, ethanol, isopropanol, n-butanol, trifluoroethanol, and ethylene glycol
- ketone solvents e.g., acetone and methyl ethyl ketone
- ether solvents e.g., tetrahydrofuran, dioxane, diethylether,
- ester solvents e.g., methyl acetate and ethyl acetate
- aprotic polar solvents e.g., acetonitrile, iV,iV-dimethylformamide, and dimethylsulfoxide
- halogenated hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., alcoholic solvents (in particular, methanol and ethanol) are preferable.
- the proportion between compound (6) and compound (7) is generally at least 1 mol, and preferably about 1 to 5 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating. The reaction is preferably conducted under temperature conditions of near-room temperature to about 85° C for 1 to 30 hours.
- compound (8) can be produced by reacting compound (6) with pyruvic acid ester (21) and a halogenating agent. It is believed that compound (7) is once generated by a reaction between pyruvic acid ester (21) and a halogenating agent, and the resulting product is reacted with compound (6) to produce compound (8 ) .
- Compound ( 7) generated by a reaction between pyruvic acid ester (21) and a halogenating agent can be reacted with compound (6) with or without isolating.
- the reaction can generally be conducted in a solvent that does not adversely affect the reaction.
- solvents include those used in the reaction between compound (6) and compound (7) described above.
- halogenating agents include halogens (X 2 2: wherein X 2 is a halogen atom, such as chlorine, bromine, and iodine), and iV-halosuccinimides (e.g., N-chlorosuccinimide, N- bromosuccinimide, iV-iodosuccinimide, etc.). Among these, bromine is preferable.
- the proportion between compound (6) and pyruvic acid ester (21) is generally at least 1 mol and preferably about 1 to 5 mol of the latter per mole of the former.
- the proportion between pyruvic acid ester (21) and the halogenating agent is generally at least 1 mol and preferably about 1 to 5 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and may generally be conducted under cooling, at room temperature, or under heating. Preferably, the reaction is conducted under temperature conditions of near room temperature to about the boiling point of the solvent for 1 to 30 hours.
- Compound (9) can be produced by debenzylating compound
- the reaction can generally be conducted in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- solvents include water, alcoholic solvents (e.g., methanol, ethanol. isopropanol, n-butanol, trifluoroethanol, and ethylene glycol), aprotic polar solvents (e.g., amide solvents such as N,N- dimethylformamide and N,N-dimethylacetamide) , and mixed solvents thereof.
- alcoholic solvents e.g., methanol and ethanol
- ethanol are preferable.
- catalysts suitable for the debenzylation reaction include platinum catalysts (e.g., platinum plate, spongy platinum, platinum black, colloidal platinum, platinum oxide, and platinum wire), palladium catalysts (e.g., spongy palladium, palladium black, palladium oxide, palladium carbon,
- platinum catalysts e.g., platinum plate, spongy platinum, platinum black, colloidal platinum, platinum oxide, and platinum wire
- palladium catalysts e.g., spongy palladium, palladium black, palladium oxide, palladium carbon
- palladium/barium sulfate, and palladium/barium carbonate nickel catalysts (e.g., reduced nickel, nickel oxide, and Raney nickel), cobalt catalysts (e.g., reduced cobalt and Raney cobalt), and iron catalysts (e.g., reduced iron).
- nickel catalysts e.g., reduced nickel, nickel oxide, and Raney nickel
- cobalt catalysts e.g., reduced cobalt and Raney cobalt
- iron catalysts e.g., reduced iron.
- palladium catalysts in particular, palladium black, palladium oxide, and palladium carbon are preferable.
- the amount of catalyst used for the debenzylation reaction is not particularly limited, and is preferably, for example, 5 to 10 parts by weight per 100 parts by weight of compound (8).
- the reaction is conducted in a hydrogen atmosphere wherein the pressure of hydrogen is generally about 0.1 to 0.5 MPa.
- the reaction temperature is generally about 0 to 120° C, and the reaction time is generally about 30 minutes to 24 hours.
- Compounds (9) + (10) ⁇ (!!) are generally about 0 to 120° C, and the reaction time is generally about 30 minutes to 24 hours.
- Compound (11) can be produced by reacting compound (9) with compound (10) in the presence of a base.
- Examples of lower alkyl groups represented by R 11 include Ci-C 6 (in particular, C1-C4) linear or branched alkyl groups. Specific examples thereof include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 1- ethylpropyl, n-pentyl, neopentyl, n-hexyl, isohexyl, and 3- methylpentyl . Among these, methyl and ethyl are preferable.
- halogen substituted lower alkyl groups represented by R 11 include lower alkyl groups in which at least one (preferably, 1 to 7, in particular 1 to 3) hydrogen atoms bonded to a carbon atom of the lower alkyl groups as above is/are substituted with halogen atom(s).
- Specific examples thereof include fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, dichloromethyl, trifluoromethyl,
- chlorodifluoromethyl bromodifluoromethyl, trichloromethyl, 2- fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, heptafluoropropyl, and heptafluoroisopropyl .
- difluoromethyl is preferable.
- halogen atoms represented by Y include
- fluorine and chlorine are preferable.
- alkali metal atoms represented by R 12 examples include lithium, sodium, and potassium. Among these, sodium is preferable.
- Examples of lower alkyl groups represented by R 12 include Ci-C 6 (in particular, C 1 -C4) linear or branched alkyl groups. Specific examples thereof include methyl, ethyl, n-propyl, sopropyl, n- butyl, isobutyl, sec-butyl, tert-butyl, 1-ethylpropyl, n-pentyl, neopentyl, n-hexyl, isohexyl, and 3-methylpentyl. Among these, methyl and ethyl are preferable.
- Examples of groups represented by the formula above include -CF 2 COONa, -CCl 2 COONa, -CF 2 COOCH 3 , and -CF 2 COOCH 2 CH 3 .
- Examples of lower alkyl groups and halogen substituted lower alkyl groups represented by R 1 include the lower alkyl groups and halogen substituted lower alkyl groups represented by R 11 described above.
- halogen atoms represented by X 3 include fluorine, chlorine, bromine, and iodine. Among these, chlorine, bromine, and iodine are preferable. .
- the reaction can generally be conducted in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- solvents include ketone solvents (e.g., acetone and methyl ethyl ketone).
- ether solvents e.g.
- ester solvents e.g., methyl acetate and ethyl acetate
- aprotic polar solvents e.g., acetonitrile, N,iV-dimethylformamide, and dimethylsulfoxide
- halogenated hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., iV,]V-dimethylformamide is preferable.
- inorganic and organic bases can be used as the bases.
- inorganic bases include alkali metals (e.g., sodium and potassium), alkali metal hydrogencarbonates (e.g., lithium hydrogencarbonate, sodium hydrogencarbonate, and
- alkali metal hydroxides e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide
- alkali metal carbonates e.g., lithium
- alkali metal lower ( Ci-C 3 ) alkoxides e.g., sodium methoxide and sodium ethoxide
- alkali metal hydrides e.g., sodium hydride and potassium hydride
- organic bases examples include trialkylamines (e.g., trimethylamine, triethylamine, and N,N-diisopropylethylamine) , pyridine, quinoline, piperidine, imidazole, picoline, 4-dimethylaminopyridine, N r N-dimethylaniline, JV-methylmorpholine, l,5-diazabicyclo[4.3.0]non-5-ene (DBN) , 1,4- diazabicyclo[ 2.2.2 ] octane (DABCO), and 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU) .
- TBN 1,4- diazabicyclo[ 2.2.2 ] octane
- DBU 1,8- diazabicyclo[5.4.0]undec-7-ene
- bases When these bases are in a liquid form, they may also be used as a solvent.
- These bases may be used singly or as
- the amount of base used is generally 1 to 10 mol, and preferably 1 to 6 mol per mole of compound (9).
- alkali metal iodides such as potassium iodide and sodium iodide, may be added to the reaction system as reaction accelerators, if necessary.
- the amount used is at least 1 mol, and preferably about 1 to 5 mol per mole of compound (10).
- the proportion between compound (9) and compound (10) is generally at least 1 mol, and preferably about 1 to 5 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted either under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of near room temperature to about 85° C for 1 to 30 hours.
- Compound (12) can be produced by reducing compound (11).
- the reaction is generally conducted by reacting compound (11) with a reducing agent in a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include ether solvents (e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane, and diglyme), alcoholic solvents (e.g., methanol, ethanol, isopropanol, n-butanol, trifluoroethanol, and ethylene glycol), and mixed solvents thereof.
- ether solvents in particular, dimethoxyethane
- dimethoxyethane are preferable.
- reducing agents include hydride reducing agents. Specific examples thereof include sodium borohydride, zinc borohydride (Zn(BH 4 ) 2 ), tetramethylammonium
- borane* THF complex borane* dimethylsulfide complex, and lithium aluminium hydride are preferable, and zinc borohydride is
- the amount of reducing agent used is generally 0.5 to 10 mol, and preferably 0.5 to 6 mol per mole of compound (11).
- zinc borohydride can generally be prepared using sodium borohydride and zinc halide (ZnX 5 2 : wherein X 5 is a halogen atom, such as chlorine and
- the proportion of zinc halide and sodium borohydride is generally 1 to 5 mol, preferably 1.5 to 2.5 mol, and particularly preferably about 2 mol of the latter per mole of the former.
- the amount of zinc halide used is generally 0.5 to 10 mol, and preferably 0.5 to 6 mol per mole of compound (11).
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating. Preferably, the reaction is conducted under temperature conditions of near room temperature to about 100° C for 1 to 30 hours.
- Compound (13) can be produced by converting the hydroxy group of compound (12) into a leaving group (X 4 ).
- Examples of leaving groups represented by X 4 include halogen atoms (e.g., fluorine, chlorine, bromine, and iodine), and organic sulfonyloxy groups (e.g., p-toluenesulfonyloxy, methanesulfonyloxy, trifluoromethanesulfonyloxy,
- halogen atoms e.g., fluorine, chlorine, bromine, and iodine
- organic sulfonyloxy groups e.g., p-toluenesulfonyloxy, methanesulfonyloxy, trifluoromethanesulfonyloxy
- halogen atom is preferable, and bromine is
- compound (13') wherein the leaving group represented by X 4 is an organic sulfonyloxy group
- compound (13') can be produced by reacting compound (12), in a solvent and in the presence of a base, with organic sulfonyl halide or organic sulfonyl anhydride containing organic sulfonyl group.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylethe ,
- ester solvents e.g., methyl acetate and ethyl acetate
- aprotic polar solvents e.g., acetonitrile, iV,lV-dimethylformamide, and dimethylsulfoxide
- halogenated hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., methylene chloride and ethylene chloride
- inorganic and organic bases can be used as the bases.
- inorganic bases include alkali metal
- hydrogencarbonates e.g., lithium hydrogencarbonate, sodium hydrogencarbonate, and potassium hydrogencarbonate
- alkali metal hydroxides e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide
- alkali metal carbonates e.g., lithium carbonate, sodium carbonate, potassium carbonate, and cesium carbonate
- alkali metal hydrides e.g., sodium
- organic bases include trialkylamines (e.g., trimethylamine, triethylamine, and N,N- diisopropylethylamine) , pyridine, quinoline, piperidine,
- organic sulfonyl halides examples include p- toluenesulfonyl halide, methanesulfonyl halide,
- halides include chloride, and bromide. Among these, chloride is
- organic sulfonyl anhydrides examples include p- toluenesulfonic anhydride, methanesulfonic anhydride,
- the amount of base used is generally 1 to 10 mol, and preferably 1 to 6 mol per mole of compound (12).
- the amount of organic sulfonyl halide or organic sulfonyl anhydride used is generally 1 to 5 mol, and preferably 1 to 2 mol per mole of compound (12).
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of about 0 to 60° C for 1 to 30 hours.
- Compound (13") wherein the leaving group represented by X 4 is a halogen atom, can be produced by reacting a
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether,
- ester solvents e.g., methyl acetate and ethyl acetate
- aprotic polar solvents e.g., acetonitrile, N,N-dlmethylformamide, and dimethylsulfoxide
- halogenated hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- halogenating agents include alkali metal halides (e.g., lithium chloride, lithium bromide, lithium iodide, etc.), and quaternary ammonium halides (e.g., tetrabutylammonium chloride and tetrabutylammonium bromide) .
- alkali metal halides in particular, lithium bromide
- quaternary ammonium halides e.g., tetrabutylammonium chloride and tetrabutylammonium bromide
- the amount of halogenating agent used is generally 1 to 5 mol, and preferably 1 to 3 mol per mole of compound (13').
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of about 0 to 60° C for 1 to 30 hours.
- the compound (13) (including compound (13') and compound (13'')) thus obtained may be supplied to the subsequent reaction process.
- Compound (15) can be produced by reacting compound (13) with compound (14).
- alkali metal atoms represented by M examples include lithium, sodium, and potassium. Among these, potassium is
- the reaction may generally be conducted in a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction. Examples thereof include ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g. , tetrahydrofuran, dioxane, diethylether, dimethoxyethane, and diglyme), ester solvents (e.g., methyl acetate and ethyl acetate), aprotic polar solvents (e.g., acetonitrile, N,N- dimethylformamide, and dimethylsulfoxide) , halogenated
- hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., N,N- dimethylformamide is particularly preferable.
- the proportion of compound (13) and compound (14) used is generally at least 1 mol, and preferably about 1 to 5 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of about 0 to 100° C for 1 to 30 hours.
- Compound (16) can be produced by reacting compound (15) with methylamine.
- the reaction may generally be conducted in a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include water, alcoholic solvents (e.g., methanol, ethanol, isopropanol, n- butanol, trifluoroethanol, and ethylene glycol), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane. and diglyme), aprotic polar solvents (e.g., acetonitrile, N,N- dimethylformamide, and dimethylsulfoxide) , and mixed solvents thereof.
- alcoholic solvents e.g., methanol, ethanol, isopropanol, n- butanol, trifluoroethanol, and ethylene glycol
- ether solvents e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane. and diglyme
- methylamine can be used in the form of an aqueous solution of methylamine.
- the amount of methylamine used is generally 1 to 10 mol, and preferably 1 to 5 mol per mole of compound (15).
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under temperature conditions of near room temperature to about 100° C for 10 minutes to 30 hours .
- the resulting compound (16) is a primary amine compound. From the viewpoint of handleability, compound (16) may be
- the acid used may be selected from a wide variety of organic or inorganic acids.
- organic acids include organic carboxylic acids such as formic acid, acetic acid, lactic acid, tartaric acid, and succinic acid; and sulfonic acids such as methanesulfonic acid, toluenesulfonic acid, and naphthalenesulfonic acid.
- inorganic acids include hydrochloric acid, sulfuric acid, nitric acid, and phosphoric acid.
- Compound (1) can be produced by subjecting compound (16) to a condensation reaction with compound (17) or compound (17' ).
- Ar 1 is phenyl substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- alkyl groups include Ci-C 4 alkyl groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, and tert-butyl. Among these, methyl and ethyl are preferable.
- Examples of halogen substituted lower alkyl groups include halogen substituted C 1 -C4 alkyl groups such as
- fluoromethyl difluoromethyl, trifluoromethyl, and 2,2,2- trifluoroethyl.
- difluoromethyl and trifluoromethyl are preferable.
- lower alkoxy groups include C 1 -C4 alkoxy such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butyloxy, isobutyloxy, sec-butyloxy, and tert-butyloxy. Among these, methoxy and ethoxy are preferable.
- halogen substituted lower alkoxy groups examples include halogen substituted C 1 -C4 alkoxy groups such as
- fluoromethoxy difluoromethoxy, trifluoromethoxy, and 2,2,2- trifluoroethoxy.
- difluoromethoxy is preferable.
- Phenyl group has 1 to 3 (preferably, 1) substituents selected from the group consisting of the above-mentioned substituents .
- substituted phenyl group represented by Ar 1 include lower alkylphenyl groups (e.g., 2- methylphenyl and 2-ethylphenyl) , halogen substituted lower alkylphenyl groups (e.g., 2-fluoromethylphenyl, 2- difluoromethylphenyl, and 2-trifluoromethylphenyl) , lower alkoxyphenyl groups (e.g., 2-methoxyphenyl and 2-ethoxyphenyl) , and halogen substituted lower alkoxyphenyl groups (e.g., 2- fluoromethoxyphenyl, 2-difluoromethoxyphenyl, and 2- trifluoromethoxyphenyl) .
- 2-methylphenyl, 2- difluoromethoxyphenyl, and 2-ethoxyphenyl are preferable.
- Ar 1 is pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- lower alkyl groups include C 1 -C4 alkyl groups such as methyl, ethyl, n- propyl, xsopropyl, n-butyl, isobutyl, sec-butyl, and tert-butyl. Among these, methyl and ethyl are preferable.
- halogen substituted lower alkyl groups include halogen substituted C 1 -C4 alkyl groups such as fluoromethyl, difluoromethyl, trifluoromethyl, and 2,2,2- trifluoroethyl. Among these, difluoromethyl and trifluoromethyl are preferable.
- lower alkoxy groups include Ci-C 4 alkoxy groups such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butyloxy, isobutyloxy, sec-butyloxy, and tert-butyloxy. Among these, methoxy and ethoxy are preferable.
- halogen substituted lower alkoxy groups examples include halogen substituted Ci-C 4 alkoxy groups such as
- fluoromethoxy difluoromethoxy, trifluoromethoxy, and 2,2,2- trifluoroethoxy.
- difluoromethoxy is preferable.
- Pyridyl group has 1 to 3 (preferably, 1) substituents selected from the group consisting of above-mentioned
- substituted-pyridyl groups represented by Ar 1 include lower alkylpyridyl groups (e.g., 3- methylpyridin-2-ly and 3-ethylpyridin-2-ly) , halogen substituted lower alkylpyridyl groups (e.g., 3-fluoromethylpyridin-2-ly, 3- difluoromethylpyridin-2-ly, and 3-trifluoromethylpyridin-2-ly) , lower alkoxypyridyl groups (e.g., 3-methoxypyridin-2-ly and 3- ethoxypyridin-2-ly) , and halogen substituted lower alkoxypyridyl groups (e.g., 3-fluoromethoxypyridin-2-ly, 3- difluoromethoxypyridin-2-ly, and 3-trifluoromethoxypyridin-2-ly) .
- 3-methylpyridin-2-ly is preferable.
- the reaction between compound (16) and compound (17) may generally be conducted in a solvent and in the presence of a condensing agent.
- the reaction may be conducted after removing the acid from the salt to convert the salt into compound (16), which is a free primary amine, using a base.
- usable bases include inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, and sodium hydrogencarbonate; and organic bases such as triethylamine, iV,iV-diisopropylethylamine.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include halogenated aliphatic hydrocarbon solvents (e.g., methylene chloride, chloroform, and ethylene chloride), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane, and diglyme) , aromatic hydrocarbons (e.g., toluene and xylene), aprotic polar solvents (e.g., acetonitrile, N,W-dimethylformamide, -methylpyrrolidone, and dimethylsulfoxide) , and mixed solvents thereof.
- ketone solvents in particular, acetone and methyl ethyl ketone
- ether solvents in particular,
- tetrahydrofuran dioxane, diethylether, and dimethoxyethane are preferable.
- condensing agents examples include 1,1'- carbonyldiimidazole (CDI), dicyclohexylcarbodiimide (DCC) ,
- diisopropylcarbodiimide DIC
- EDC or WSC 1-ethyl-3- ( 3- dimethylaminopropyl)carbodiimide hydrochloride
- diphenylphosphoryl azide e.g., benzotriazol-l-yloxy- tris (dimethylamino)phosphonium salt
- benzotriazol-l-yloxy- tris (dimethylamino)phosphonium hexafluorophosphate) e.g., benzotriazol-l-yloxy- tris (dimethylamino)phosphonium hexafluorophosphate
- CDM 2- chloro-4,6-dimethoxytriazine
- CDI and EDC are preferable.
- the amount of the condensing agent used is generally at least 1 mol, and preferably about 1 to 5 mol per mole of compound (17).
- 1-Hydroxybenzotriazole (HOBt) , iV-hydroxysuccinijnide (HOSu), and the like may be used as an additive (activator) in combination with a condensing agent, if necessary.
- the amount thereof is generally at least 1 mol and preferably about 1 to 5 mol per mole of condensing agent.
- the reaction may be conducted by adding a base, if necessary.
- a base examples include tertiary amines such as triethylamine and JV,JV-diisopropylethylamine; and
- nitrogen-containing aromatic compounds such as pyridine and 4- dimethylaminopyridine.
- the amount thereof is generally at least 1 mol, and preferably about 1 to 5 mol per mole of the condensing agent.
- the proportion between compound (16) and compound (17) is generally at least 1 mol, and preferably about 1 to 2 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under the temperature conditions of about 0 to 100° C for 1 to 30 hours.
- reaction between compound (16) and compound (17') is generally conducted in a solvent and in the presence of a base.
- the solvent is not particularly limited, as long as it does not adversely affect the reaction.
- examples thereof include halogenated aliphatic hydrocarbon solvents (e.g., methylene chloride, chloroform, and ethylene chloride), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether, dimethoxyethane, and diglyme) , ester solvents (e.g., methyl acetate and ethyl acetate), aromatic hydrocarbons (e.g., toluene and xylene), aprotic polar solvents (e.g., acetonitrile, N,iV-dimethylformamide, N- methylpyrrolidone, and dimethylsulfoxide) , and mixed solvents thereof.
- halogenated aliphatic hydrocarbon solvents e.g.,
- ester solvents e.g., ethyl acetate
- ketone solvents in particular, acetone and methyl ethyl ketone
- ether solvents in particular, tetrahydrofuran, dioxane, diethylether, and dimethoxyethane
- bases examples include inorganic bases such as sodium hydroxide, potassium hydroxide, sodium carbonate, and sodium hydrogen carbonate; and organic bases such as
- the amount of base used is generally at least 1 mol, and preferably about 1 to 5 mol per mole of compound (17' ).
- the proportion between compound (16) and compound (17') is generally at least 1 mol, and preferably about 1.2 to 2 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted either under cooling, at room temperature, or under heating. The reaction is preferably conducted under temperature conditions of about 0 to 100° C for 1 to 30 hours.
- the compound (17') can be obtained from compound (17) by a known method.
- compound (17') can be produced by reacting compound (17) with a halogenating agent (e.g., thionyl chloride, sulfuryl chloride, oxalyl chloride, phosphorus
- a halogenating agent e.g., thionyl chloride, sulfuryl chloride, oxalyl chloride, phosphorus
- a solvent e.g., ethyl acetate, toluene, dichloromethane, chlorobenzene
- additives e.g., DMF, DMA, and NMP
- DMF, DMA, and NMP may be added, if necessary.
- Reaction Scheme 1 can be collectively shown in formula (A) below:
- R A is a group represented by formula: -COOR 5 , -CH 2 OH,
- the intermediate compound (12) shown in Reaction Scheme 1 can be separately produced in the procedure shown in Reaction Scheme 2 below.
- Compound (29) can be produced by debenzylating compound
- reaction can be conducted by or based on the conditions for the reaction of compound (8) ⁇ (9) in Reaction Scheme 1.
- Compound (30) can be produced by reacting compound (29) with compound (10) in the presence of a base.
- the reaction can be conducted by or based on the conditions for the reaction of compound (9) + (10) ⁇ (ll) in Reaction Scheme 1.
- Compound (31) can be produced by hydrolyzing compound (30).
- the reaction can be conducted by or based on the conditions for the reaction of compound (3' ) ⁇ (5) in Reaction Scheme 1.
- the process producing compound (31) from compound (29) through compound (30) can be conducted as a one-pot process.
- Compound (28) can be produced by subjecting compound (31) to a condensation reaction with ammonia (amidation) .
- the reaction can be conducted by or based on the conditions for the reaction of compound (5)- ⁇ (6) in Reaction Scheme 1.
- the reaction producing compound (11) from compound (28) can be conducted by or based on the conditions for the reaction of compound (6) ⁇ (8) in Reaction Scheme 1.
- the reaction can be conducted by or based on the conditions for the reaction of compound (11) ⁇ (12) in Reaction Scheme 1.
- Compound (33) can be produced by reacting compound (28) with compound (32).
- alkanoyl groups represented by R 7 include Ci-C 6 (in particular, C 1 -C4) linear or branched alkanoyl groups. Specific examples thereof include formyl, acetyl, n- propionyl, xsopropionyl, n-butyryl, isobutyryl, sec-butyryl, tert-butyryl, and hexanoyl. Among these, formyl, acetyl, n- propionyl, and isopropionyl are preferable, and acetyl is
- halogen atoms represented by X 8 include fluorine, chlorine, bromine, and iodine. Among these, chlorine, bromine, and iodine are preferable.
- the reaction can generally be conducted in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- solvents include halogenated aliphatic hydrocarbon solvents (e.g.,
- aromatic hydrocarbons e.g., toluene and xylene
- aprotic polar solvents e.g., acetonitrile, iV,N-dimethylformamide, N-methylpyrrolidone, and dimethylsulfoxide
- aromatic hydrocarbons e.g., toluene and xylene
- aromatic hydrocarbons e.g., toluene and xylene
- aprotic polar solvents e.g., acetonitrile, iV,N-dimethylformamide, N-methylpyrrolidone, and dimethylsulfoxide
- the proportion between compound (28) and compound (32) is generally at least 1 mol, and preferably about 1 to 5 mol of the latter per mole of the former.
- Dehydrating agents may be added thereto, if necessary.
- the usable dehydrating agents include synthetic zeolites. Specific examples thereof include Molecular Sieves (MS) 3A, MS 4A, or zeolites having pores similar thereto.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted either under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under the temperature conditions of about room
- Compound (12) can be produced by hydrolyzing compound (33).
- the hydrolysis reaction can be conducted by or based on the conditions for the reaction of compound (3' ) ⁇ (5) in Reaction
- R 1 is preferably methyl or difluoromethyl
- R 2 is preferably methyl, isopropyl, or isobutyl.
- a preferable compound is such that R 1 is methyl, or
- R 2 is methyl, isopropyl, or isobutyl. More specifically, the preferable compound is represented by formula (12A) :
- R is methyl or difluoromethyl, R is methyl, isopropyl, or isobutyl.
- R 3 ⁇ 4 is preferably isopropyl, or isobutyl
- R ⁇ is preferably methyl, isopropyl or isobutyl
- the target compound in each step in Reaction Scheme 1 and Reaction Scheme 2, after completion of the reaction, can be obtained from the reaction mixture by a known isolation operation (such as filtration, concentration, or extraction).
- isolation operation such as filtration, concentration, or extraction.
- the method of the present invention does not use 1,3-dihaloacetone and
- Reaction Scheme 2 is desirable as a process for the industrial-scale production of a compound represented by formula (1) because it enables the efficient formation of an oxazole ring midway through a series of reaction processes.
- the compound represented by formula (2) can be produced through the reaction steps shown in Reaction Scheme 3.
- R 3 is lower alkyl group or halogen substituted lower alkyl group
- R 4 is lower alkyl group, cycloalkyl-lower alkyl group or lower alkenyl group
- R 6 is lower alkyl group
- Ar 2 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group, or pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- X 6 is a leaving group
- X 7 is a halogen atom
- R 5 and X 2 are as defined above.
- Ester compound (18) can be produced by esterifying
- Examples of lower alkyl groups represented by R 3 include Ci-C 6 (in particular, C 1 -C4) linear or branched alkyl groups.
- methyl, ethyl, isopropyl, and isobutyl are preferable, methyl and ethyl are more preferable, and methyl is particularly preferable.
- halogen substituted lower alkyl groups represented by R 3 include lower alkyl groups in which at least one (preferably, 1 to 7, in particular 1 to 3) hydrogen atoms bonded to a carbon atom of the lower alkyl groups as above is/are substituted with halogen atom(s).
- bromodifluoromethyl trichloromethyl, 2-fluoroethyl, 2- chloroethyl, 2-bromoethyl, 2, 2-difluoroethyl, 2,2,2- trifluoroethyl, pentafluoroethyl, heptafluoropropyl, and
- heptafluoroisopropyl Among these, difluoromethyl is preferable.
- the reaction described above may be conducted by, for example, reacting carboxylic acid compound (18' ) with methanol in the presence of an acid (e.g., p-toluenesulfonic acid) to obtain ester compound (18).
- the reaction may also be conducted by reacting carboxylic acid compound (18') with a halogenating agent (e.g., thionyl chloride) to obtain a carboxylic acid halide, and reacting the carboxylic acid halide with methanol to obtain ester compound (18).
- a halogenating agent e.g., thionyl chloride
- Compound (19) can be produced by converting the hydroxyl group of compound (18) into benzyloxy group
- the benzylation described above can generally be conducted by reacting compound (18) with benzyl halide in a solvent and in the presence of a base.
- the solvent is not particularly limited, as long as it does not adversely affect the reaction.
- examples thereof include water, alcoholic solvents (e.g., methanol, ethanol, isopropanol, n-butanol), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane.
- ester solvents e.g., methyl acetate and ethyl acetate
- aromatic hydrocarbons e.g., toluene and xylene
- aprotic polar solvents e.g., acetonitrile, JV,2V-dimethylformamide, and dimethylsulfoxide
- hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., methylene chloride and ethylene chloride
- inorganic and organic bases can be used as the bases.
- inorganic bases include alkali metal
- hydrogencarbonates e.g., lithium hydrogencarbonate, sodium hydrogencarbonate, and potassium hydrogencarbonate
- alkali metal hydroxides e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide
- alkali metal carbonates e.g., lithium carbonate, sodium carbonate, potassium carbonate, and cesium carbonate
- alkali metal lower (Ci-C 3 ) alkoxides e.g., sodium methoxide and sodium ethoxide
- organic bases examples include trialkylamines (e.g., trimethylamine, triethylamine, and iV,JV-diisopropylethylamine) , pyridine, quinoline, piperidine, imidazole, picoline, 4-dimethylaminopyridine, ]V,iV-dimethylaniline, W-methylmorpholine, 1 , 5-diazabicyclo[4.3.0]non-5-ene (DB ) , 1,4- diazabicyclo[ 2.2.2]octane (DABCO) , and 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU) .
- trialkylamines e.g., trimethylamine, triethylamine, and iV,JV-diisopropylethylamine
- pyridine quinoline
- piperidine imidazole
- picoline 4-dimethylaminopyridine
- the amount of base used is generally 0.5 to 10 mol, and
- phase transfer catalyst In order to promote the reaction, a phase transfer catalyst may be added.
- phase transfer catalysts include quaternary ammonium salts, such as tetrabutylammonium fluoride (TBAF), tetrabutylammonium chloride (TBAC), and
- TBAB tetrabutylammonium bromide
- the amount thereof is generally 0.01 to 0.5 mol, and preferably 0.05 to 0.3 mol per mole of compound (18).
- benzyl halides include benzyl chloride, benzyl bromide, and benzyl iodide.
- the proportion between compound (18) and benzyl halide is generally at least 1 mol, and preferably about 1 to 5 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under the temperature conditions of about 0 to 100° C for 1 to 30 hours.
- the hydrolysis reaction can be conducted by or based on the conditions for the reaction of compound (3' ) ⁇ (5) in Reaction Scheme 1.
- Compound (20) can be produced by subjecting compound
- reaction (19) to a condensation reaction with ammonia (amidation) .
- the reaction can be conducted by or based on the conditions for the reaction of compound (5) ⁇ (6) in Reaction Scheme 1.
- Compound (22) can be produced by reacting compound (20) with compound (7). More specifically, it can be produced by reacting compound (20) with compound (7), or by reacting compound
- reaction can be conducted by or based on the conditions for the reaction of compound (6) ⁇ (8) in Reaction Scheme 1.
- Compound (23) can be produced by reducing compound (22).
- the reaction can be conducted by or based on the conditions for the reaction of compound (11) ⁇ (12) in Reaction Scheme 1.
- Compound (24) can be produced by converting the hydroxy1 group of compound (23) to a leaving group (X 6 ).
- Examples of leaving groups represented by X 6 include halogen atoms (e.g., fluorine, chlorine, bromine, and iodine), and organic sulfonyloxy groups (e.g., p-toluenesulfonyloxy, methanesulfonyloxy, trifluoromethanesulfonyloxy,
- halogen atoms e.g., fluorine, chlorine, bromine, and iodine
- organic sulfonyloxy groups e.g., p-toluenesulfonyloxy, methanesulfonyloxy, trifluoromethanesulfonyloxy
- halogen atoms are preferable, and bromine is
- the reaction can be conducted by or based on the conditions for the reaction of compound (12) ⁇ (13) in Reaction Scheme 1. More specifically, in the case of compound (24') whose leaving group (X 6 ) is organic sulfonyloxy, the reaction can be conducted by or based on the reaction for producing compound
- reaction can be conducted by or based on the reaction for producing compound (13'').
- Compound (26) can be produced by reacting compound (24) with compound (25) and then treating the resultant with an acid.
- lower alkyl groups represented by R 6 include Ci-C 6 (in particular, Ci-C 3 ) linear or branched alkyl groups.
- methyl and ethyl are preferable.
- substituent represented by Ar 2 is phenyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- lower alkyl groups include C1-C4 alkyl groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, and tert-butyl. Among these, methyl and ethyl are preferable.
- halogen substituted lower alkyl groups examples include halogen substituted C1-C4 alkyl groups such as
- fluoromethyl difluoromethyl, trifluoromethyl, and 2,2,2- trifluoroethyl.
- difluoromethyl is preferable.
- lower alkoxy groups include Ci-C 4 alkoxy groups such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butyloxy, isobutyloxy, sec-butyloxy, and tert-butyloxy. Among these, methoxy and ethoxy are preferable.
- halogen substituted lower alkoxy groups include halogen substituted C 1 -C4 alkoxy groups such as
- fluoromethoxy difluoromethoxy, trifluoromethoxy, and 2,2,2- trifluoroethoxy.
- Phenyl group has 1 to 3 (preferably, 1) substituents selected from the above-mentioned substituents.
- substituted-phenyl group represented by Ar 2 include lower alkylphenyl groups (e.g., 2- methylphenyl and 2-ethylphenyl) , halogen substituted lower
- alkylphenyl groups e.g., 2-fluoromethylpheny1, 2- difluoromethylphenyl, and 2-trifluoromethylphenyl
- alkoxyphenyl groups e.g., 2-methoxyphenyl and 2-ethoxyphenyl
- halogen substituted lower alkoxyphenyl groups e.g., 2- fluoromethoxyphenyl, 2-difluoromethoxyphenyl, and 2- trifluoromethoxyphenyl
- 2-methylphenyl, 2- difluoromethoxyphenyl, and 2-ethoxyphenyl are preferable.
- substituent represented by Ar 2 is pyridyl group substituted with at least one substituent selected from the group consisting of lower alkyl group, halogen substituted lower alkyl group, lower alkoxy group and halogen substituted lower alkoxy group
- lower alkyl groups include C 1 -C4 alkyl groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, and tert-butyl. Among these, methyl and ethyl are preferable.
- halogen substituted lower alkyl groups examples include halogen substituted Ci-C 4 alkyl groups such as
- lower alkoxy groups include C 1 -C4 alkoxy groups such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butyloxy, isobutyloxy, sec-butyloxy, and tert-butyloxy.
- halogen substituted lower alkoxy groups examples include halogen substituted C 1 -C4 alkoxy groups such as
- Pyridyl group has 1 to 3 (preferably, 1) substituents selected from the group consisting of the above-mentioned
- substituted-pyridyl groups represented by Ar 2 include lower alkylpyridyl groups (e.g., 3- methylpyridin-2-ly and 3-ethylpyridin-2-ly) , halogen substituted lower alkylpyridyl groups (e.g., 3-fluoromethylpyridin-2-ly, 3- difluoromethylpyridin-2-ly, and 3-trifluoromethylpyridin-2-ly) , lower alkoxypyridyl groups (e.g., 3-methoxypyridin-2-ly and 3- ethoxypyridin-2-ly) , and halogen substituted lower alkoxypyridyl groups (e.g., 3-fluoromethoxypyridin-2-ly, 3- difluoromethoxypyridin-2-ly, and 3-trifluoromethoxypyridin-2-ly) .
- 3-methylpyridin-2-ly is preferable.
- Compound (26) can be produced by reacting compound (24) with compound (25) in a solvent and in the presence of a base, and then treating the result with an acid.
- the solvent used in the reaction between compound (24) and compound (25) is not particularly limited as long as it does not adversely affect the reaction.
- examples thereof include ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane, diethylether, and diglyme), ester solvents (e.g., methyl acetate and ethyl acetate), aprotic polar solvents (e.g., acetonitrile, iV,N-dimethylformamide, and dimethylsulfoxide) , halogenated hydrocarbon solvents (e.g., methylene chloride and ethylene chloride) , and mixed solvents thereof.
- iV,]V-dimethylformamide is preferable.
- inorganic bases As the bases, known inorganic and organic bases can be used.
- inorganic bases include alkali metals (e.g. , sodium and potassium), alkali metal hydrogencarbonates (e.g., lithium hydrogencarbonate, sodium hydrogencarbonate, and
- alkali metal hydroxides e.g., lithium hydroxide, sodium hydroxide, potassium hydroxide, and cesium hydroxide
- alkali metal carbonates e.g., lithium
- alkali metal lower ( Ci-C 3 ) alkoxides e.g., sodium methoxide and sodium ethoxide
- alkali metal hydrides e.g., sodium hydride and potassium hydride
- organic bases examples include trialkylamines (e.g., trimethylamine, triethylamine, and W,iV-diisopropylethylamine) , pyridine, quinoline, piperidine, imidazole, picoline, 4-dimethylaminopyridine, JV,N-dimethylaniline, iV-methylmorpholine, 1,5-diazabicyclo[4.3.0]non-5-ene (DBN) , 1,4- diazabicyclo [ 2.2.2 ]octane (DABCO), and 1,8- diazabicyclo[5.4.0]undec-7-ene (DBU) .
- these bases When these bases are in a liquid form, they may also be used as a solvent.
- these bases may be used singly or as a mixture of two or more.
- alkali metal carbonates e.g., lithium carbonate, sodium
- the amount of base used is generally 0.5 to 20 mol, and preferably 0.5 to 5 mol per mole of compound (25).
- the proportion between compound (24) and compound (25) is generally at least 1 mol, and preferably about 1 to 5 mol of the latter per mole of the former.
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under the temperature conditions of about 0 to 100° C for 1 to 30 hours.
- R 3 , R 6 and Ar 2 are as defined above.
- Compound (26' ) is subsequently supplied to the reaction with an acid.
- reaction of compound (26' ) with an acid can be conducted in a solvent by reacting compound (26' ) with an acid, wherein compound (26) can be produced through hydrolyzation, decarboxylation, and debenzylation.
- the solvent is not particularly limited, as long as it does not adversely affect the reaction.
- examples thereof include water, alcoholic solvents (e.g., methanol, ethanol, isopropanol, and n-butanol), ketone solvents (e.g., acetone and methyl ethyl ketone), ether solvents (e.g., tetrahydrofuran, dioxane,
- ester solvents e.g., methyl acetate and ethyl acetate
- aromatic hydrocarbons e.g., toluene and xylene
- aprotic polar solvents e.g., acetonitrile, iV,JV-dimethylformamide, and dimethylsulfoxide
- hydrocarbon solvents e.g., methylene chloride and ethylene chloride
- mixed solvents thereof e.g., water and alcoholic solvents (e.g., methanol and ethanol) are preferable.
- inorganic and organic acids may be used as the acid.
- inorganic acids include hydrohalic acids (e.g., hydrochloric acid and hydrobromic acid) , sulfuric acid, nitric acid, and phosphoric acid.
- organic acids include formic acid, acetic acid, propionic acid, p-toluenesulfonic acid, methanesulfonic acid, and trifluoromethanesulfonic acid. When these acids are in a liquid form, they may be used as a solvent. These acids may be used singly or as a mixture of two or more.
- inorganic acids are preferable, and hydrohalic acids (in particular, hydrobromic acid) are particularly preferable.
- the amount of acid used is generally 0.5 to 100 mol and preferably 1 to 50 mol per mole of compound (26').
- the reaction temperature is not particularly limited, and the reaction may generally be conducted under cooling, at room temperature, or under heating.
- the reaction is preferably conducted under the temperature conditions of about 0 to 100° C for 1 to 30 hours.
- Compound (26) can thus be produced.
- Compound (25) is commercially available, or can be synthesized by or based on the method disclosed in a document such as Hong-yu Li et al.. Tetrahedron, 2007, 63, 11763-11770.
- Compound (26) + (27) ⁇ (2) is commercially available, or can be synthesized by or based on the method disclosed in a document such as Hong-yu Li et al.. Tetrahedron, 2007, 63, 11763-11770.
- Compound (26) + (27) ⁇ (2) is commercially available, or can be synthesized by or based on the method disclosed in a document such as Hong-yu Li et al.. Tetrahedron, 2007, 63, 11763-11770.
- Compound (2) can be produced by reacting compound (26) with compound (27) in the presence of a base.
- Examples of lower alkyl groups represented by R 4 include Ci-C 6 (in particular, Ci-C 4 ) linear or branched alkyl groups.
- methyl, ethyl, isopropyl, and isobutyl are preferable.
- cycloalkyl lower alkyl groups represented by R 4 include C 3 -C 6 cycloalkyl Ci-C 3 alkyl groups. Specific
- examples thereof include cyclopropyl methyl, 2- (cyclopropyl)ethyl, 3- (cyclopropyl)propyl, cyclobutyl methyl, 2- (cyclobutyl)ethyl, and 3- (cyclobutyl)propyl.
- cyclopropyl methyl and cyclobutyl methyl are preferable.
- Examples of lower alkenyl groups represented by R 4 include C 2 -C 6 (in particular, C 2 -C 4 ) linear or branched alkenyl groups. Specific examples thereof include vinyl, allyl, and crotyl. Among these, allyl is preferable.
- halogen atoms represented by X 7 include fluorine, chlorine, bromine, and iodine. Among these, chlorine, bromine, and iodine are preferable.
- the reaction can be conducted by or based on the conditions for the reaction of compound (3) ⁇ (3' ) or compound
- reaction mixture by a known isolation operation (such as
- the method of the present invention does not use 1,3-dihaloacetone, which is
- the production method of the present invention does not use a dihaloketone compound, which is harmful to humans, or explosive hydrazine throughout the production processes thereof, it is preferable from the viewpoint of the health and/or safety of the people who are involved in its production.
- Compound (2a) was produced according to the following reactions .
- Compound (22a) can also be produced by reacting compound (20a) and ethyl bromopyruvate (7a) according to Step (1- 3) of Example 1.
- Compound (2b) was obtained by performing the treatment in the same manner as or according to Steps (7-4) to (7-8) of Example 7, except that known Compound (20b) was used in place of Compound (20a).
- the 3 ⁇ 4 NMR data of the compound produced in each step is shown below.
- Compound (22b) can be produced by reacting Compound (20b) with ethyl bromopyruvate (7a).
- EtOH (740 ml) was added to the resulting oil and dissolved, and concentrated hydrochloric acid (148 ml) was added thereto, followed by heating at reflux for one hour.
- EtOH was distilled off, and then water (740 ml), toluene (1480 ml) and a 25% NaOH aqueous solution (148 ml) were added to the residue, and extraction and liquid separation was performed.
- the organic layer was washed with water (740 ml), it was concentrated to dryness to obtain an oily product.
- MeOH (592 ml) was added to the resulting oil and dissolved, and a 25% NaOH aqueous solution (104 ml) was added, followed by heating at reflux for one hour.
- Toluene (50.0 ml) was added to Compound (28a) (50.0 g, 204 mmol) and molecular sieves 3A (MS 3A) (50.0 g) , and 1-acetoxy 3-chloroacetone (1,3-ACA) (36.0 ml, 1.5 eq.) was added thereto, followed by heating at reflux for 22 hours. After toluene (100 ml) was added and the mixture was cooled to room temperature, MS 3A was removed by filtration. Toluene (250 ml), water (100 ml), and a 25% NaOH aqueous solution (25 ml) were added to the resulting solution, and extraction and liquid separation was performed.
- the resulting organic layer was concentrated to dryness to obtain an oily product.
- the resulting oil was dissolved in MeOH (250 ml), and water (200 ml) and a 25% NaOH aqueous solution (50 ml) were added thereto, followed by heating at reflux for 15 minutes. After the resulting mixture was cooled, the precipitated crystals were collected by filtration and dried at 80°C to obtain a crude product of Compound (12a).
- the crude product was heated and dissolved in MeOH (100 ml), and water (100 ml) was added thereto. After the reaction mixture was cooled, the precipitated crystals were collected by filtration and dried at 80°C to give Compound (12a) (49.6 g) .
- EtOH (195 ml) was added to the resulting oil and dissolved, and concentrated hydrochloric acid (19.5 ml) was added thereto, and heated at reflux for one hour. After the completion of the reaction, EtOH was distilled off, and then water (195 ml), toluene (351 ml), and a 25% NaOH aqueous solution (39 ml) were added to the residue, and extraction and liquid separation was performed. After the organic layer was washed with water (195 ml), it was concentrated to dryness to obtain an oily product. MeOH (156 ml) was added to the resulting oil and dissolved, and a 25% NaOH aqueous solution (27 ml) was added thereto, followed by heating at reflux for one hour.
- Compound (lb) was obtained by the treatment according to Example 20, except that Compound (16b) and (17b) were used in place of Compound (16a) and (17a).
- the production method of the present invention does not use a dihaloketone compound, which is harmful to humans, throughout the production processes thereof, it is preferable from the viewpoint of the health and/or safety of the people who are involved in its production. Furthermore, since this method allows purification without using column chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
Claims
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13779396.4A EP2890686B1 (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
| BR112015004023A BR112015004023A2 (en) | 2012-08-30 | 2013-08-29 | compound, and method for producing a compound |
| KR1020157007577A KR102016973B1 (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
| US14/423,896 US9181205B2 (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
| RU2015111236A RU2015111236A (en) | 2012-08-30 | 2013-08-29 | METHOD FOR PRODUCING OXAZOLE DERIVATIVE |
| JP2014560591A JP6253598B2 (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
| CN201380045266.1A CN104603116A (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
| CA2880882A CA2880882A1 (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
| IL237052A IL237052A0 (en) | 2012-08-30 | 2015-02-02 | Method for producing oxazole compound |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695056P | 2012-08-30 | 2012-08-30 | |
| US61/695,056 | 2012-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2014034958A1 true WO2014034958A1 (en) | 2014-03-06 |
Family
ID=49385321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2013/073854 Ceased WO2014034958A1 (en) | 2012-08-30 | 2013-08-29 | Method for producing oxazole compound |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9181205B2 (en) |
| EP (1) | EP2890686B1 (en) |
| JP (1) | JP6253598B2 (en) |
| KR (1) | KR102016973B1 (en) |
| CN (3) | CN104603116A (en) |
| BR (1) | BR112015004023A2 (en) |
| CA (1) | CA2880882A1 (en) |
| IL (1) | IL237052A0 (en) |
| RU (1) | RU2015111236A (en) |
| WO (1) | WO2014034958A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017115780A1 (en) | 2015-12-28 | 2017-07-06 | Otsuka Pharmaceutical Co., Ltd. | Ointment |
| WO2019194211A1 (en) | 2018-04-04 | 2019-10-10 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| WO2023182468A1 (en) | 2022-03-25 | 2023-09-28 | 大塚製薬株式会社 | Wound treatment composition |
| WO2024231312A2 (en) | 2023-05-05 | 2024-11-14 | UNION therapeutics A/S | Combination therapy |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116194451B (en) * | 2020-11-27 | 2025-07-11 | 瑞石生物医药有限公司 | Aryl or heteroaryl substituted five-membered aromatic heterocyclic compound and its use |
| CN115785014B (en) * | 2022-12-27 | 2025-01-24 | 瑞石生物医药有限公司 | Tetrazolyl derivatives and uses thereof |
| CN119798183B (en) * | 2024-12-19 | 2026-03-24 | 上海药坦药物研究开发有限公司 | A method for preparing an oxazole compound |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472386B1 (en) * | 2001-06-29 | 2002-10-29 | Kowa Co., Ltd. | Cyclic diamine compound with 5-membered ring groups |
| WO2007058338A2 (en) | 2005-11-15 | 2007-05-24 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound and pharmaceutical composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5872571A (en) * | 1981-10-27 | 1983-04-30 | Shionogi & Co Ltd | Production of 2-guanidino-4-(2-(formamide) ethylthiomethyl)thiazole |
| JP4986927B2 (en) * | 2007-05-14 | 2012-07-25 | 大塚製薬株式会社 | Medicine |
-
2013
- 2013-08-29 EP EP13779396.4A patent/EP2890686B1/en active Active
- 2013-08-29 US US14/423,896 patent/US9181205B2/en active Active
- 2013-08-29 KR KR1020157007577A patent/KR102016973B1/en active Active
- 2013-08-29 WO PCT/JP2013/073854 patent/WO2014034958A1/en not_active Ceased
- 2013-08-29 RU RU2015111236A patent/RU2015111236A/en unknown
- 2013-08-29 CN CN201380045266.1A patent/CN104603116A/en active Pending
- 2013-08-29 JP JP2014560591A patent/JP6253598B2/en active Active
- 2013-08-29 CN CN201910152842.1A patent/CN109879828A/en active Pending
- 2013-08-29 BR BR112015004023A patent/BR112015004023A2/en not_active IP Right Cessation
- 2013-08-29 CN CN201910130142.2A patent/CN109912526A/en active Pending
- 2013-08-29 CA CA2880882A patent/CA2880882A1/en not_active Abandoned
-
2015
- 2015-02-02 IL IL237052A patent/IL237052A0/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472386B1 (en) * | 2001-06-29 | 2002-10-29 | Kowa Co., Ltd. | Cyclic diamine compound with 5-membered ring groups |
| WO2007058338A2 (en) | 2005-11-15 | 2007-05-24 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound and pharmaceutical composition |
| JP2009515872A (en) | 2005-11-15 | 2009-04-16 | 大塚製薬株式会社 | Oxazole compounds and pharmaceutical compositions |
Non-Patent Citations (3)
| Title |
|---|
| HONG-YU LI ET AL., TETRAHEDRON, vol. 63, 2007, pages 11763 - 11770 |
| JUAN F. SANZ-CERVERA ET AL: "Solution versus Fluorous versus Solid-Phase Synthesis of 2,5-Disubstituted 1,3-Azoles. Preliminary Antibacterial Activity Studies", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 74, no. 23, 4 December 2009 (2009-12-04), pages 8988 - 8996, XP055087190, ISSN: 0022-3263, DOI: 10.1021/jo9016265 * |
| TETRAHEDRON, vol. 63, 2007, pages 11763 - 11770 |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240034867A (en) | 2015-12-28 | 2024-03-14 | 오츠카 세이야쿠 가부시키가이샤 | Ointment |
| KR20180097672A (en) | 2015-12-28 | 2018-08-31 | 오츠카 세이야쿠 가부시키가이샤 | Ointment |
| KR20250044948A (en) | 2015-12-28 | 2025-04-01 | 오츠카 세이야쿠 가부시키가이샤 | Ointment |
| US10588893B2 (en) | 2015-12-28 | 2020-03-17 | Otsuka Pharmaceutical Co., Ltd. | Ointment containing an oxazole compound |
| WO2017115780A1 (en) | 2015-12-28 | 2017-07-06 | Otsuka Pharmaceutical Co., Ltd. | Ointment |
| KR20200139736A (en) * | 2018-04-04 | 2020-12-14 | 오츠카 세이야쿠 가부시키가이샤 | Oxazole compound crystal |
| US11840512B2 (en) | 2018-04-04 | 2023-12-12 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| US11414391B2 (en) | 2018-04-04 | 2022-08-16 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| EP4400167A2 (en) | 2018-04-04 | 2024-07-17 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| EP4400167A3 (en) * | 2018-04-04 | 2024-09-25 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| IL277730B1 (en) * | 2018-04-04 | 2024-10-01 | Otsuka Pharma Co Ltd | Oxazole compound crystal |
| IL277730B2 (en) * | 2018-04-04 | 2025-02-01 | Otsuka Pharma Co Ltd | Oxazole compound crystal |
| KR102764726B1 (en) * | 2018-04-04 | 2025-02-11 | 오츠카 세이야쿠 가부시키가이샤 | Oxazole compound crystals |
| WO2019194211A1 (en) | 2018-04-04 | 2019-10-10 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| AU2024220015B2 (en) * | 2018-04-04 | 2026-03-26 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound crystal |
| WO2023182468A1 (en) | 2022-03-25 | 2023-09-28 | 大塚製薬株式会社 | Wound treatment composition |
| KR20240165411A (en) | 2022-03-25 | 2024-11-22 | 오츠카 세이야쿠 가부시키가이샤 | Composition for wound healing |
| WO2024231312A2 (en) | 2023-05-05 | 2024-11-14 | UNION therapeutics A/S | Combination therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2880882A1 (en) | 2014-03-06 |
| KR20150046285A (en) | 2015-04-29 |
| US9181205B2 (en) | 2015-11-10 |
| EP2890686A1 (en) | 2015-07-08 |
| US20150239855A1 (en) | 2015-08-27 |
| IL237052A0 (en) | 2015-03-31 |
| CN109879828A (en) | 2019-06-14 |
| EP2890686B1 (en) | 2017-01-04 |
| CN109912526A (en) | 2019-06-21 |
| BR112015004023A2 (en) | 2017-07-04 |
| RU2015111236A (en) | 2016-10-20 |
| JP6253598B2 (en) | 2017-12-27 |
| JP2015528433A (en) | 2015-09-28 |
| KR102016973B1 (en) | 2019-09-02 |
| CN104603116A (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102016973B1 (en) | Method for producing oxazole compound | |
| AU2015282127B2 (en) | Method for producing fused heterocyclic compound | |
| US20220081385A1 (en) | Novel salts and polymorphic form of bempedoic acid | |
| EP2451786B1 (en) | Improved process for the preparation of ambrisentan and novel intermediates thereof | |
| TW201625634A (en) | Synthesis of COPANLISIB and its dihydrochloride | |
| US11939322B2 (en) | Method for producing tetracyclic compound | |
| JP2011168577A (en) | Method for producing 2-amino-4-trifluoromethylpyridines | |
| CN103387547B (en) | A kind of method preparing phonetic mite amine | |
| JP2013166752A (en) | Industrial process for preparation of 1,2-dihydroquinoline derivative or salt thereof, and intermediate for preparation thereof | |
| TW202012372A (en) | Process for producing 2-(fluoroalkyl) nicotinic acids | |
| JP2012509267A5 (en) | (R) -3- (2,3-dihydroxypropyl) -6-fluoro-5- (2-fluoro-4-iodophenylamino) -8-methylpyrido [2,3-d] pyrimidine-4,7 (3H , 8H) -Dione and its intermediate for production | |
| JP7689742B2 (en) | 1,4-dihydro-4-oxoquinoline-2-carboxylates and methods for preparing 4-aminoquinoline compounds therefrom | |
| JP5282029B2 (en) | Preparation of quinolonecarboxylic acid derivatives | |
| HK40007530A (en) | Method for producing oxazole compound | |
| HK40007532A (en) | Method for producing oxazole compound | |
| US20150274624A1 (en) | Process for the preparation of ospemifene | |
| EP2935239B1 (en) | Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide | |
| KR20190002643A (en) | Process for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives | |
| WO2014087428A1 (en) | Process for preparation of vilazodone and intermediates thereof | |
| WO2025256582A1 (en) | Method for preparing pharmaceutical intermediate of 2-oxo-1,2-dihydroquinoline derivative | |
| WO2025085310A1 (en) | Processes for the preparation of substituted phenylacetonitriles and substituted phenylacetic acids | |
| TW202604494A (en) | Preparation method of pharmaceutical intermediates of 2-oxo-1,2-dihydroquinoline derivatives | |
| CN112979643A (en) | 3-(2-Chloroethyl)-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | |
| JP2000327622A (en) | Production of phenylacetic acid derivative | |
| JP2017206453A (en) | Process for producing pyrazole derivatives and intermediates thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13779396 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2014560591 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 237052 Country of ref document: IL |
|
| ENP | Entry into the national phase |
Ref document number: 2880882 Country of ref document: CA |
|
| REEP | Request for entry into the european phase |
Ref document number: 2013779396 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2013779396 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 14423896 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 20157007577 Country of ref document: KR Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2015111236 Country of ref document: RU Kind code of ref document: A |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015004023 Country of ref document: BR |
|
| ENP | Entry into the national phase |
Ref document number: 112015004023 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150225 |














































